| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.052 | 0.3 |